Drug-labels.com

Apo-Abiraterone: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
250 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Apo-Abiraterone

ABOUT THIS MEDICATION

What the medication is used for:

APO-ABIRATERONE, in combination with prednisone, is used to treat prostate cancer that has spread to other parts of the body in:

  • adult patients who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy (ADT).

    or

  • adult patients who have had prior cancer treatment with docetaxel after failure of ADT

Asymptomatic patients are defined as patients who may have no noticeable changes to health. Mildly symptomatic patients may show symptoms or changes in health such as bone pain or fatigue.

What it does:

APO-ABIRATERONE works to stop your body from making androgens. This can slow the growth of prostate cancer. APO-ABIRATERONE may help delay the decline in your daily activity levels and may help delay the need for drugs to treat your cancer pain.

When your prostate cancer spreads beyond the prostate to other parts of the body, this is known as metastatic prostate cancer or advanced cancer.

Androgens are a group of hormones, and testosterone belongs to this group. Testosterone is the main type of androgen. Androgens promote cancer cell growth. That is why it’s so important to keep these hormones at “castrate levels” (extremely low levels), to stop the growth of cancer.

APO-ABIRATERONE helps to block the production of even small amounts of androgens in the three places they are produced: in the testes, the adrenal glands and the prostate cancer tumor itself.

When it should not be used:

  • If you are allergic (hypersensitive) to abiraterone acetate or any of the other ingredients of APO-ABIRATERONE.
  • APO-ABIRATERONE should not be taken by women who are pregnant or might be pregnant

  • APO-ABIRATERONE should not be taken by women who are nursing.

What the medicinal ingredient is:

Abiraterone acetate

What the nonmedicinal ingredients are:

APO-ABIRATERONE 250 mg uncoated tablets: colloidal silicon dioxide, crospovidone, lactose monohydrate, magnesium stearate and sodium lauryl sulfate

What dosage forms it comes in:

250 mg uncoated tablets.

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions

  • APO-ABIRATERONE may cause high blood pressure, low blood potassium and swelling (fluid retention).
  • APO-ABIRATERONE should be used with caution in patients with a history of heart failure, heart attack, or other heart problems.
  • Patients with severe and moderate liver problems should not take APO-ABIRATERONE.
  • Cases of liver failure, some leading to death have been reported. (see below for more information).

APO-ABIRATERONE must be taken on an empty stomach since food can increase the blood level of APO-ABIRATERONE and this may be harmful. Do not eat any solid or liquid food two hours before taking APO-ABIRATERONE and at least one hour after taking APO-ABIRATERONE

BEFORE you use APO-ABIRATERONE talk to your doctor or pharmacist if:

  • you have or have had high blood pressure, low blood potassium and irregular heartbeats
  • you have diabetes
  • you have or have had heart failure, heart attack, or other heart problems
  • you have liver problems
  • you have or have had adrenal problems

APO-ABIRATERONE may affect your liver. Rarely, failure of the liver to function (called acute liver failure)

may occur, which can lead to death. Talk to your doctor if you develop yellowing of the skin or eyes, darkening of the urine, or severe nausea or vomiting, as these could be signs or symptoms of liver problems. When you are taking APO-ABIRATERONE your doctor will check your blood to look for any effects of APO-ABIRATERONE on your liver.

APO-ABIRATERONE may affect your blood sugar levels if you have diabetes. Your blood sugar might drop if you take APO-ABIRATERONE plus prednisone/prednisolone with drugs for diabetes, like pioglitazone or repaglinide. Your physician will check your blood sugar levels while you are taking these drugs with APO-ABIRATERONE plus prednisone/prednisolone.

APO-ABIRATERONE may harm an unborn baby. While taking APO-ABIRATERONE and for one week after the last dose of APO-ABIRATERONE, male patients must use a condom and another effective birth control method when having sexual activity with a women who is pregnant or can become pregnant.

Women who are pregnant or may become pregnant should not handle APO-ABIRATERONE 250 mg uncoated tablets without protective gloves.

APO-ABIRATERONE should not be used in patients under 18 years of age.

INTERACTIONS WITH THIS MEDICATION

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines. This includes medicines obtained without a prescription, including herbal medicines.

Tell your physician if you are taking phenytoin, carbamazepine, rifampicin, rifabutin, phenobarbital, or St. John’s wort because these medications may decrease the effect of APO-ABIRATERONE. This may lead to APO-ABIRATERONE not working as well as it should.

Tell your physician if you are taking drugs for diabetes, like pioglitazone or repaglinide. Your blood sugar might drop if you take these drugs with APO-ABIRATERONE plus prednisone/prednisolone.

PROPER USE OF THIS MEDICATION

Always take APO-ABIRATERONE exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.

Usual dose:

The usual dose is four 250 mg tablets (1g) by mouth once a day.

APO-ABIRATERONE must be taken on an empty stomach

  • Do not eat any solid or liquid food two hours before taking APO-ABIRATERONE and at least one hour after taking APO-ABIRATERONE. Taking APO-ABIRATERONE with food causes more of this medicine to be absorbed by the body than is needed and this may be harmful.
  • Swallow the tablets whole with a glass of water.
  • Do not break the tablets.
  • APO-ABIRATERONE is taken with a medicine called prednisone to help manage potential side effects such as fluid in your legs or feet and muscle weakness, muscle twitches or a pounding heart beat (palpitations) which may be signs of low blood potassium (see Side Effects section below). Take the prednisone exactly as your doctor has told you.

Overdose

If you think you have taken too much APO-ABIRATERONE, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

Missed dose:

If you forget to take APO-ABIRATERONE or prednisone, take your normal dose the following day.

If you forget to take APO-ABIRATERONE or prednisone for more than one day, talk to your doctor without delay.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like all medicines, APO-ABIRATERONE can cause side effects, although not everybody gets them. The following side effects may happen with this medicine:

Very Common (affects more than 1 in 10 people):

  • Joint swelling or pain, muscle pain
  • Hot flushes
  • Cough
  • Diarrhea
  • Fatigue
  • Constipation
  • Vomiting
  • Insomnia
  • Anemia
  • High blood pressure

Common (affects less than 1 in 10 people):

  • High fat levels in your blood
  • Liver function test increases
  • Heart failure
  • Rapid or irregular heart rate associated with feeling faint or lightheaded
  • Upper and lower respiratory infection
  • Stomach upset / Indigestion
  • Flu-like symptoms
  • Weight increase
  • Urinary frequency
  • Bone break (fracture)
  • Presence of blood in your urine
  • Rash and skin lesions
  • Falls
  • Bruising
  • Headache
  • Depression

Uncommon (affects less than 1 in 100 people):

  • Adrenal gland problems

Reported from post-marketing with unknown frequency

  • Lung irritation - Symptoms may include shortness of breath, cough and fatigue.

Reported from post-marketing with very rare frequency

  • Anaphylactic-allergic reactions

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

Your blood pressure, blood sugar, serum potassium, signs and symptoms of fluid retention will be monitored clinically by your doctor.

SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Very Common
Muscle weakness, muscle twitches or a pounding heart beat (palpitations). These may be signs of low level of potassium in your blood.✓
Swollen hands, legs, ankles or feet✓
Burning on urination or cloudy urine (Urinary✓

SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
tract infection)
Common
Chest pain✓

Irregular heartbeat

(Heart beat disorder) that can be associated with feeling faint, lightheaded, chest pain, a racing heartbeat, a slow heartbeat, shortness of breath, sweating, or a fluttering in your chest.

✓
Rapid heart rate✓
Unknown
Shortness of breath✓
Breakdown of muscle tissue and muscle weakness and/or muscle pain✓
Yellowing of the skin or eyes, darkening of the urine, or severe nausea or vomiting (Failure of the liver to function/ acute liver failure)✓
Allergic reactions that include, but are not limited to difficulty swallowing or breathing, swollen face or lips, tongue or throat, or an itchy rash called urticaria.✓
Very Rare
Thirst, frequent urination, hunger, nausea and dizziness, fast heartbeat, tingling trembling, nervousness, sweating, low energy (low blood sugar)✓

This is not a complete list of side effects. For any unexpected effects while taking APO-ABIRATERONE, contact your doctor or pharmacist.

HOW TO STORE IT

APO-ABIRATERONE tablets should be stored at 15ºC to 30ºC. Keep out of the reach and sight of children.

Do not use APO-ABIRATERONE after the expiry date which is stated on the label. The expiry date refers to the last day of the month.

Medicines should not be thrown away via wastewater or household waste. Throw away any unused product or waste material in accordance with local requirements. If you are not sure, ask your pharmacist how to throw away medicines no longer required. These measures will help to protect the environment.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about APO-ABIRATERONE:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Consumer Information by visiting the Health Canada website (https://health-products.canada.ca/dpd-bdpp/index-eng.jsp). Find the Consumer Information on the manufacturer’s website http://www.apotex.ca/products, or by calling 1-800-667-4708.

Last revised: May 28, 2021

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02473917

Revision date stated in the text: May 28, 2021

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Apo-Abiraterone

Rx or OTC
Prescription (Rx)?
DIN 02473917
Schedule(s) PRESCRIPTION
Active ingredient(s) Abiraterone acetate 250 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. L Antineoplastic and immunomodulating agents
    1. L02 Endocrine therapy antineoplastic and immunomodulating agents
      1. L02B Hormone antagonists and related agents
        1. L02BX Other hormone antagonists and related agents
          1. L02BX03 Abiraterone
Company APOTEX INC
Current status Approved
Current status date January 11, 2021

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.